Numerous studies have reported that high expression of CSF-1 or its receptor CSF-1R is associated with poor prognosis in malignant tumors, such as in breast cancer and Hodgkin’s lymphoma (62, 97, 108). Here, CSF1R is linked to Hodgkins lymphoma.